Related references
Note: Only part of the references are listed.Current strategies and progress for targeting the undruggable transcription factors
Jing-jing Zhuang et al.
ACTA PHARMACOLOGICA SINICA (2022)
PROTAC targeted protein degraders: the past is prologue
Miklos Bekes et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer
Nathalie Broutet et al.
PREVENTIVE MEDICINE (2022)
The role of cell-penetrating peptides in potential anti-cancer therapy
Meiling Zhou et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Assessing the Future of Solid Tumor Immunotherapy
Prajna Guha et al.
BIOMEDICINES (2022)
Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future
Rui Li et al.
MOLECULES (2022)
High-potency PD-1/PD-L1 degradation induced by Peptide-PROTAC in human cancer cells
Meng-Yuan Dai et al.
CELL DEATH & DISEASE (2022)
PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras
Jyotsana Madan et al.
BIODRUGS (2022)
REVIEW Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical Cancer
Yanjun Ge et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2022)
Target and tissue selectivity of PROTAC degraders
Robert G. Guenette et al.
CHEMICAL SOCIETY REVIEWS (2022)
Targeted Protein Degradation: An Important Tool for Drug Discovery for Undruggable Tumor Transcription Factors
Mengyuan Dai et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2022)
Targeted protein degradation: mechanisms, strategies and application
Lin Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway
Qian Wu et al.
ACTA PHARMACOLOGICA SINICA (2021)
Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis
F. Solorzano-Ibarra et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy
Junyu Yang et al.
CANCER RESEARCH (2021)
Pembrolizumab for advanced cervical cancer: safety and efficacy
Francesca De Felice et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
Fluoxetine and Ketamine Reverse the Depressive but Not Anxiety Behavior Induced by Lesion of Cholinergic Neurons in the Horizontal Limb of the Diagonal Band of Broca in Male Rat
Linghong Chen et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)
Advances in targeting 'undruggable' transcription factors with small molecules
Matthew J. Henley et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma et al.
CANCER DISCOVERY (2021)
The PROTACtable genome
Melanie Schneider et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Peptide-Based Drug Delivery Systems
Dmitriy Berillo et al.
MEDICINA-LITHUANIA (2021)
A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity
Siqi Yan et al.
THERANOSTICS (2021)
SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
Andrew R. McGill et al.
INFECTIOUS DISEASE REPORTS (2021)
A review of cancer immunotherapy toxicity
Lucy Boyce Kennedy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Preventive and Therapeutic Effects of Astaxanthin on Depressive-Like Behaviors in High-Fat Diet and Streptozotocin-Treated Rats
Yuting Ke et al.
FRONTIERS IN PHARMACOLOGY (2020)
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2020)
Preparation of Biphenyl-Conjugated Bromotyrosine for Inhibition of PD-1/PD-L1 Immune Checkpoint Interactions
Eun-Hye Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer
Hongwei Liao et al.
CELL DISCOVERY (2020)
Recent trends in protein and peptide-based biomaterials for advanced drug delivery
Anastasia Varanko et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker
Zhengyi Wang et al.
CANCER MEDICINE (2020)
The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
Katie Hudson et al.
FRONTIERS IN IMMUNOLOGY (2020)
Trappc9 deficiency in mice impairs learning and memory by causing imbalance of dopamine D1 and D2 neurons
Yuting Ke et al.
SCIENCE ADVANCES (2020)
CA-170-A Potent Small-Molecule PD-L1 Inhibitor or Not?
Bogdan Musielak et al.
MOLECULES (2019)
Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This Disease
Tanja Sarenac et al.
FRONTIERS IN PHARMACOLOGY (2019)
Computational Insight Into the Small Molecule Intervening PD-L1 Dimerization and the Potential Structure-Activity Relationship
Danfeng Shi et al.
FRONTIERS IN CHEMISTRY (2019)
Hitting Undruggable Targets: Viewing Stabilized Peptide Development through the Lens of Quantitative Systems Pharmacology
Lydia Atangcho et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Systemic therapy for cervical carcinoma - current status
Krystyna Serkies et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis
Niloy Ranjan Datta et al.
GYNECOLOGIC ONCOLOGY (2017)
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
Jean-Sebastien Frenel et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells
Lukasz Skalniak et al.
ONCOTARGET (2017)
Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
Roland Boettger et al.
PLOS ONE (2017)
Phospholipase C gamma mediates endogenous brain-derived neurotrophic factor-regulated calcitonin gene-related peptide expression in colitis-induced visceral pain
Fiza Hashmi et al.
MOLECULAR PAIN (2016)
INFLAMMATION AND ACTIVITY AUGMENT BRAIN-DERIVED NEUROTROPHIC FACTOR PERIPHERAL RELEASE
L. Y. Qiao et al.
NEUROSCIENCE (2016)
Impact of V-ets Erythroblastosis Virus E26 Oncogene Homolog 1 Gene Polymorphisms Upon Susceptibility to Autoimmune Diseases A Meta-Analysis
Ye Zhou et al.
MEDICINE (2015)
Statistical Issues in Longitudinal Data Analysis for Treatment Efficacy Studies in the Biomedical Sciences
Chunyan Liu et al.
MOLECULAR THERAPY (2010)